M. Kabbaj et al., OPPOSITE EFFECTS ON HIPPOCAMPAL CORTICOSTEROID RECEPTORS INDUCED BY STIMULATION OF BETA-NORADRENERGIC AND ALPHA-1-NORADRENERGIC RECEPTORS, Neuroscience, 66(3), 1995, pp. 539-545
Central corticosteroid receptors play an important role in the regulat
ion of the secretion of corticosterone. Although these receptors are t
hought to be regulated by circulating levels of corticosterone, there
is evidence for direct neural control. For example, it has been shown
that noradrenergic lesions can both increase and decrease corticostero
id receptors depending on the brain structure involved. In the present
study, we investigated the role of different noradrenergic receptors
in the rat, by examining the effect of the acute administration of ago
nists and antagonists of beta and alpha(1) noradrenergic receptors on
hippocampal type I and type II corticosteroid receptor levels. The eff
ects of these drugs were studied in adrenalectomized animals whose pla
sma levels of corticosterone were maintained in the physiological rang
e by implantation of corticosterone pellets. Our results show that the
beta receptor agonist salbutamol (5 mg/kg) increased the number of ty
pe I and type II hippocampal corticosteroid receptors. This effect was
blocked by the beta receptor antagonist propranolol (5 mg/kg), which
had no effect on its own. In contrast, the alpha(1) receptor agonist p
henylephrine (100 mu g) reduced the number of type I and type II corti
costeroid receptors, whereas the alpha(1) receptor antagonist prazosin
(0.5 mg/kg) increased type I receptors. The effect of prazosin was at
tributed to an increase in the relative beta tonus resulting from bloc
kade of alpha(1) receptors. Its effect was reversed by the simultaneou
s injection of the beta receptor antagonist propranolol. In conclusion
, our results show that noradrenergic transmission can have both a fac
ilitatory and an inhibitory action on central corticosteroid receptors
by acting respectively on beta and alpha(1) noradrenergic receptors.
Since noradrenergic neurons and the hypothalamo-pituitary-adrenal axis
are known to be involved in various psychopathological conditions, th
ese results may be relevant to treatment for dysregulation of corticos
terone secretion.